| Application # | Type | Sponsor | Notes | Product # | Drug Name | Form | Strength | Active Ingredient | Approval Date | Marketing Status | Reference Standard |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 761238 | BLA | TG THERAPEUTICS, INC | 001 | BRIUMVI | INJECTABLE;INTRAVENOUS | 25 MG/ML | UBLITUXIMAB-XIIY | 2022-12-28 | Prescription | No |